Related Experiment Video
Updated: Mar 27, 2026

Developing 3D Organized Human Cardiac Tissue within a Microfluidic Platform
Published on: June 15, 2021
Beating heart on a chip: a novel microfluidic platform to generate functional 3D cardiac microtissues
Anna Marsano1, Chiara Conficconi2, Marta Lemme2
1Departments of Surgery and Biomedicine, University Basel, University Hospital Basel, Hebelstrasse 20, 4031 Basel, Switzerland. anna.marsano@usb.ch.
Researchers developed a novel heart-on-a-chip platform applying controlled mechanical strain to 3D cardiac tissues. This engineered cardiac micro-niche enhances tissue function and offers new avenues for drug discovery and disease modeling.
Area of Science:
- Biomedical Engineering
- Cardiovascular Research
- Tissue Engineering
Background:
- Microfluidic technology has advanced cardiac microscale models, but replicating native myocardial mechanical cues in 3D remains a challenge.
- Existing 2D models neglect complex 3D cell-cell and cell-matrix interactions crucial for cardiac function.
Purpose of the Study:
- To develop a heart-on-a-chip platform capable of applying controlled physiological uniaxial cyclic strains to 3D cell constructs.
- To create a robust and functional engineered cardiac micro-niche that mimics the native myocardial mechanical environment.
Main Methods:
- A novel heart-on-a-chip device featuring hanging posts and a pneumatic actuation system was designed to induce uniaxial cyclic strain.
- The platform was used to culture micro-engineered cardiac tissues (μECTs) from neonatal rat and human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM).
Main Results:
- Stimulated μECTs exhibited superior cardiac differentiation, electrical and mechanical coupling, and increased junction complexes compared to controls.
- The cyclic strain was effectively uniaxial and uniformly transferred, promoting early synchronous beating and enhanced contractile function.
- Drug testing on hiPSC-CM constructs demonstrated the platform's utility in drug discovery, delivery, and toxicology.
Conclusions:
- The developed heart-on-a-chip platform provides a standardized, functional 3D cardiac model that recapitulates physiological mechanical stimulation.
- This advanced model holds potential for predicting hypertrophic changes and advancing cardiac research, drug development, and toxicology assessments.
More Related Videos
10:37Fabrication of 3D Cardiac Microtissue Arrays using Human iPSC-Derived Cardiomyocytes, Cardiac Fibroblasts, and Endothelial Cells
Published on: March 14, 2021
12:28Designing a Bioreactor to Improve Data Acquisition and Model Throughput of Engineered Cardiac Tissues
Published on: June 2, 2023